Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.

Journal Article

An attempt was made to produce tumor immunity in 193 patients who had melanoma, 160 of whom had metastases and 33 of whom did not. Four stages of treatment are outlined. The patients whose disease was confined to the skin, subcutaneous tissues, and lymph nodes seemed to benefit most. The treatment was of no benefit to patients whose disease had progressed to the visceral, skeletal, or central nervous systems.

Full Text

Duke Authors

Cited Authors

  • Seigler, HF; Shingleton, WW; Pickrell, KL

Published Date

  • March 1, 1975

Published In

Volume / Issue

  • 55 / 3

Start / End Page

  • 294 - 298

PubMed ID

  • 1118487

International Standard Serial Number (ISSN)

  • 0032-1052

Language

  • eng

Conference Location

  • United States